TY - JOUR
T1 - Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis
T2 - Secondary, exploratory analysis of data from the CogEx trial
AU - CogEx Research Team
AU - Motl, Robert W.
AU - Sandroff, Brian M.
AU - Hernandez, Roberto S.
AU - Amato, Maria Pia
AU - Brichetto, Giampaolo
AU - Chataway, Jeremy
AU - Chiaravalloti, Nancy D.
AU - Cutter, Gary
AU - Dalgas, Ulrik
AU - DeLuca, John
AU - Farrell, Rachel
AU - Feys, Peter
AU - Filippi, Massimo
AU - Freeman, Jennifer
AU - Inglese, Matilde
AU - Meza, Cecilia
AU - Rocca, Maria A.
AU - Salter, Amber
AU - Feinstein, Anthony
N1 - Publisher Copyright:
© The Author(s), 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Background: There is heterogeneity of aerobic fitness (VO2peak) changes with a standardized exercise training stimulus in the general population (i.e. some participants demonstrate improvements, others no change, and some a reduction in VO2peak). Objectives: This secondary, exploratory analysis of data examined the heterogeneity of VO2peak responses and possible correlates among persons with progressive multiple sclerosis (PMS) from the CogEx trial. Methods: CogEx was a multi-site, multi-arm, randomized, double-blinded, and sham-controlled trial undertaken by 11 sites in six different countries. Participants were randomized into one of four conditions with different combinations of exercise training and cognitive rehabilitation including respective sham conditions. The analysis focuses primarily on VO2peak change for the pooled exercise training intervention conditions compared with the pooled sham exercise control conditions. Results: Waterfall plots for change in VO2peak suggested greater heterogeneity with exercise training than sham, and the proportions of difference in VO2peak change (i.e. improvement/worsening) were significantly different between exercise training and sham conditions(p < 0.05). The multivariable analysis indicated that lower baseline VO2peak (p < 0.001) was the only statistically significant correlate of increases in VO2peak with exercise training. Conclusion: Our results highlight the heterogeneity of change in VO2peak with exercise training that is correlated with initial aerobic capacity in PMS, and such results may inform hypothesis testing in future clinical trials of exercise training.
AB - Background: There is heterogeneity of aerobic fitness (VO2peak) changes with a standardized exercise training stimulus in the general population (i.e. some participants demonstrate improvements, others no change, and some a reduction in VO2peak). Objectives: This secondary, exploratory analysis of data examined the heterogeneity of VO2peak responses and possible correlates among persons with progressive multiple sclerosis (PMS) from the CogEx trial. Methods: CogEx was a multi-site, multi-arm, randomized, double-blinded, and sham-controlled trial undertaken by 11 sites in six different countries. Participants were randomized into one of four conditions with different combinations of exercise training and cognitive rehabilitation including respective sham conditions. The analysis focuses primarily on VO2peak change for the pooled exercise training intervention conditions compared with the pooled sham exercise control conditions. Results: Waterfall plots for change in VO2peak suggested greater heterogeneity with exercise training than sham, and the proportions of difference in VO2peak change (i.e. improvement/worsening) were significantly different between exercise training and sham conditions(p < 0.05). The multivariable analysis indicated that lower baseline VO2peak (p < 0.001) was the only statistically significant correlate of increases in VO2peak with exercise training. Conclusion: Our results highlight the heterogeneity of change in VO2peak with exercise training that is correlated with initial aerobic capacity in PMS, and such results may inform hypothesis testing in future clinical trials of exercise training.
KW - Exercise
KW - heterogeneity
KW - progressive MS
UR - http://www.scopus.com/inward/record.url?scp=85212204005&partnerID=8YFLogxK
U2 - 10.1177/20552173241301030
DO - 10.1177/20552173241301030
M3 - Article
AN - SCOPUS:85212204005
SN - 2055-2173
VL - 10
JO - Multiple Sclerosis Journal - Experimental, Translational and Clinical
JF - Multiple Sclerosis Journal - Experimental, Translational and Clinical
IS - 4
ER -